Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Liuyuan, Liu"'
Autor:
Wusheng Deng, Yanmei Lei, Xiujia Tang, Dingbin Li, Jinhua Liang, Jing Luo, Liuyuan Liu, Wenshu Zhang, Liumei Ye, Jinliang Kong, Ke Wang, Zhaoyan Chen
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Anti-infection strategies against pleural empyema include the use of antibiotics and drainage treatments, but bacterial eradication rates remain low. A major challenge is the formation of biofilms in the pleural cavity. DNase has antibiofilm efficacy
Externí odkaz:
https://doaj.org/article/d1257b877c314ddcaf8f093a82670a14
Autor:
Ke Wang, Yun Jiang, Jing Luo, Bing Huang, Jinliang Kong, Wusheng Deng, Dingbin Li, Chongxi Bao, Liuyuan Liu
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Objectives Combination treatment with erlotinib plus bevacizumab has the potential to become a standard treatment regimen for patients with epidermal growth factor receptor mutation-positive (EGFRm+) advanced non-small cell lung cancer (NSCLC). This
Externí odkaz:
https://doaj.org/article/a513bc850d194cf0a4c5854f13eeb63e
Autor:
Wusheng, Deng, Ke, Wang, Yun, Jiang, Dingbin, Li, Chongxi, Bao, Jing, Luo, Liuyuan, Liu, Bing, Huang, Jinliang, Kong
Publikováno v:
BMJ open. 12(8)
Combination treatment with erlotinib plus bevacizumab has the potential to become a standard treatment regimen for patients with epidermal growth factor receptor mutation-positive (Systematic review and meta-analysis.The PubMed, Embase, Web of Scienc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ad13ea4402e98a52265a6cf7f258197
https://pubmed.ncbi.nlm.nih.gov/35985780
https://pubmed.ncbi.nlm.nih.gov/35985780